During the past decade, Presbyterian Medical Center, PENN Comprehensive Hemophilia & Thrombosis Program conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Presbyterian Medical Center, PENN Comprehensive Hemophilia & Thrombosis Program" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Bioverativ Therapeutics Inc." with 1 trials as a collaborator, "CSL Behring" with 1 trials as a collaborator, "Shire" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Presbyterian Medical Center, PENN Comprehensive Hemophilia & Thrombosis Program" are "Hemoglobinuria, Paroxysmal" (2 trials), "Hemophilia" (1 trials) and "Von Willebrand Diseases" (1 trials). Many other conditions were trialed in "Presbyterian Medical Center, PENN Comprehensive Hemophilia & Thrombosis Program" in a lesser frequency.

Most popular intervention types in "Presbyterian Medical Center, PENN Comprehensive Hemophilia & Thrombosis Program" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "eculizumab" (2 trials), "Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013" (1 trials) and "Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013" (1 trials). Other intervention names were less common.

The vast majority of trials in "Presbyterian Medical Center, PENN Comprehensive Hemophilia & Thrombosis Program" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Presbyterian Medical Center, PENN Comprehensive Hemophilia & Thrombosis Program". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Presbyterian Medical Center, PENN Comprehensive Hemophilia & Thrombosis Program, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Presbyterian Medical Center, PENN Comprehensive Hemophilia & Thrombosis Program, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".